Kefir is a fermented milk drink produced by kefir grains—a symbiotic culture of lactic acid bacteria, yeasts, and acetic acid bacteria. Its probiotic content can modulate the gut microbiome, which in turn may influence several blood markers. Human studies suggest moderate effects on inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6), as well as improvements in fasting glucose and HbA1c in individuals with metabolic syndrome. Some evidence also points to a modest reduction in LDL cholesterol and an increase in HDL cholesterol. However, the evidence base is mixed: many studies are small, short-term, and lack standardization. The actual impact depends on the specific kefir strain, duration of consumption, and the individual's baseline gut microbiota. For healthy individuals, kefir is generally safe, but those with lactose intolerance or histamine sensitivity should exercise caution. Kefir is not a substitute for a balanced diet or medical treatment. Blood marker results should always be interpreted with clinical context.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-83781fe8c6510a2e6b12edce